[1]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35-37.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
 Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):35-37.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
点击复制

肠道菌群与2型糖尿病()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2015年01
页码:
35-37
栏目:
肠道菌群与糖尿病专栏
出版日期:
2015-01-20

文章信息/Info

Title:
Relationship between gut microbiota and type 2 diabetes
作者:
姚旻 赵爱源 张宏
300070天津医科大学研究生院(姚旻); 300252武警天津总队医院内科(姚旻);300309天津,武警后勤学院科研部(赵爱源);300070天津医科大学代谢病医院内分泌研究所,卫生部激素与发育重点实验室(张宏)
Author(s):
Yao Min* Zhao Aiyuan Zhang Hong.
*Graduate School of Tianjin Medical University, Tianjin 300070China
关键词:
2型糖尿病肠道菌群肥胖防治
Keywords:
Type 2 diabetes mellitus Gut microbiota Obesity Prevention and treatment
DOI:
DOI:10.3760/cma.j.issn.1673-4157.2015.01.008
摘要:
研究表明,2型糖尿病患者肠道菌群结构及功能与健康人不同,肠道菌群可能通过干预宿主营养及能量的吸收利用,促进脂肪的合成及存储,引发慢性低度炎性反应等机制影响2型糖尿病的发展。多项针对肠道菌群的治疗措施在2型糖尿病的动物模型和人群研究中开展,表明饮食、运动及药物均可通过干预肠道菌群的结构及功能影响糖尿病的发生和发展。干预肠道菌群可能成为今后糖尿病防治领域的重要手段之一。
Abstract:
Recent studies show that the structure and function of gut microbiota in patients with type 2 diabetes differ from those in healthy people. Gut microbiota may play roles in the development of type 2 diabetes by interfering the absorption and utilization of nutrients and energy, promoting the synthesis and storage of fat and inducing chronic lowgrade inflammation. Animal studies as well as human studies showed that diet, exercise and drugs could affect the occurrence and development of diabetes through intervening the structure and function of gut microbiota.Intervention of gut microbiota may become one of the important strategies for prevention and treatment of diabetes in the future.

参考文献/References:


[1] Cani PD,Geurts L,Matamoros S, et al.Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond[J].Diabetes Metab,2014,40(4):246-257.
[2]Larsen N,Vogensen FK,van den Berg FW, et al.Gut microbiota in human adults with type 2 diabetes differs from non diabetic adults[J].PLoS One,2010,5(2):e9085.
[3]Qin J,Li Y,Cai Z, et al.A metagenome wide association study of gut microbiota in type 2 diabetes[J].Nature,2012,490(7418):55-60.
[4]Karlsson FH,Tremaroli V,Nookaew I, et al.Gut metagenome in European women with normal, impaired and diabetic glucose control[J].Nature,2013,498(7452):99-103.
[5]Schwiertz A,Taras D,Schafer K, et al.Microbiota and SCFA in lean and overweight healthy subjects[J].Obesity (Silver Spring),2010,18(1):190-195.
[6]Diamant M,Blaak EE,de Vos WM.Do nutrient gut microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?[J].Obes Rev,2011,12(4):272-281.
[7]Remely M,Aumueller E,Merold C, et al.Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity[J].Gene,2014,537(1):85-92.
[8]Lin HV,Frassetto A,Kowalik EJ, et al.Butyrate and propionate protect against diet induced obesity and regulate gut hormones via free fatty acid receptor 3 independent mechanisms[J].PLoS One,2012,7(4):e35240.

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍:2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
 Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(01):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[4]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
 Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[5]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
 Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(01):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[6]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
 Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[7]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
 Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(01):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[8]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
 Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(01):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[9]申翘璇,陈国芳,张丹毓,等.自然疗法治疗2型糖尿病的研究进展[J].国际内分泌代谢杂志,2015,(04):280.[doi:10.3760/cma.j.issn.1673-4157.2015.04.018]
 Shen Qiaoxuan,Chen Guofang,Zhang Danyu,et al.Update on naturopathic therapy for type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):280.[doi:10.3760/cma.j.issn.1673-4157.2015.04.018]
[10]琚丽萍,田景琰.低出生体重和2型糖尿病关系的遗传学研究进展[J].国际内分泌代谢杂志,2014,(01):63.[doi:10.3760/cma.j.issn.1673-4157.2014.01.018]
 Ju Liping,Tian Jingyan..Research progress on genetics of low birth weight and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2014,(01):63.[doi:10.3760/cma.j.issn.1673-4157.2014.01.018]
[11]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
 Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]

备注/Memo

备注/Memo:
(收稿日期:2014-07-20)
更新日期/Last Update: 2015-03-24